Cargando…

Tocilizumab in patients infected by SARS-CoV2()

Detalles Bibliográficos
Autores principales: Sancho, Milagros, Muñiz, Javier, Cardinal-Fernández, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972641/
https://www.ncbi.nlm.nih.gov/pubmed/33763598
http://dx.doi.org/10.1016/j.medcle.2020.12.010
_version_ 1783666709902655488
author Sancho, Milagros
Muñiz, Javier
Cardinal-Fernández, Pablo
author_facet Sancho, Milagros
Muñiz, Javier
Cardinal-Fernández, Pablo
author_sort Sancho, Milagros
collection PubMed
description
format Online
Article
Text
id pubmed-7972641
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-79726412021-03-19 Tocilizumab in patients infected by SARS-CoV2() Sancho, Milagros Muñiz, Javier Cardinal-Fernández, Pablo Med Clin (Engl Ed) Special Article Elsevier España, S.L.U. 2021-04-23 2021-03-19 /pmc/articles/PMC7972641/ /pubmed/33763598 http://dx.doi.org/10.1016/j.medcle.2020.12.010 Text en © 2021 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Special Article
Sancho, Milagros
Muñiz, Javier
Cardinal-Fernández, Pablo
Tocilizumab in patients infected by SARS-CoV2()
title Tocilizumab in patients infected by SARS-CoV2()
title_full Tocilizumab in patients infected by SARS-CoV2()
title_fullStr Tocilizumab in patients infected by SARS-CoV2()
title_full_unstemmed Tocilizumab in patients infected by SARS-CoV2()
title_short Tocilizumab in patients infected by SARS-CoV2()
title_sort tocilizumab in patients infected by sars-cov2()
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972641/
https://www.ncbi.nlm.nih.gov/pubmed/33763598
http://dx.doi.org/10.1016/j.medcle.2020.12.010
work_keys_str_mv AT sanchomilagros tocilizumabinpatientsinfectedbysarscov2
AT munizjavier tocilizumabinpatientsinfectedbysarscov2
AT cardinalfernandezpablo tocilizumabinpatientsinfectedbysarscov2